Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Risk adjusted net present value: What is the current valuation of Soleno Therapeutics's Diazoxide choline CR?
Diazoxide choline CR is a small molecule commercialized by Soleno Therapeutics, with a leading Pre-Registration program in Prader-Willi Syndrome (PWS)....
Risk adjusted net present value: What is the current valuation of Soleno Therapeutics's Diazoxide choline CR?
Diazoxide choline CR is a small molecule commercialized by Soleno Therapeutics, with a leading Phase III program in Prader-Willi Syndrome...
Diazoxide choline CR by Soleno Therapeutics for Prader-Willi Syndrome (PWS): Likelihood of Approval
Diazoxide choline CR is under clinical development by Soleno Therapeutics and currently in Pre-Registration for Prader-Willi Syndrome (PWS). According to...